Keywords: EUSA Pharma, Ohara Pharma, Erwinase, Cancer drug, License, Japan

EUSA Pharma enters first Japanese accord, granting Erwinase rights to Ohara Pharmaceutical

Article | 07 July 2010

Print This

UK and USA-based specialty drugmaker EUSA Pharma has granted the Japanese development and commercialization rights to its oncology therapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in